A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
Trial ID or NCT#
NCT06388707
Status
NOT RECRUITING
Purpose
This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).
Official Title
A Prospective, Open-label, Single-arm, Multi-center, Pilot Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Unilateral or Bilateral Temporal Lobe Epilepsy
Investigator(s)
RobertÌýFisher, MD, PhD
Epilepsy specialist,
Neurophysiologist,
Neurologist
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Contact us to find out if this trial is right for you.
Contact
SPECTRUM
650-725-6648
View on